Three-quarters of patients would recommend artificial intelligence as a component of clinical decision-making for skin cancer, according to a survey.

“The use of artificial intelligence (AI) is expanding throughout the field of medicine,” Caroline A. Nelson, MD, of the department of dermatology at Yale School of Medicine, and colleagues wrote, adding that researchers are investigating the use of AI in classifying skin lesions. “Although AI is poised to change how patients engage in health care, patient perspectives remain poorly understood.”